Assessing the Dependence of Feeding Gastrostomy Tube in Patients of Head and Neck Carcinomas

Authors

  • Rabeeta Sheikh Department of Oncology, Shaukat Khanam Memorial Cancer Hospital, & Research Centre Peshawar Pakistan
  • Muhammad Sohaib Nadeem Department of Oncology, Combined Military Hospital/National University of Medical Sciences (NUMS) Rawalpindi Pakistan
  • Nadia Khaleeq Khyber Medical University, Peshawar Pakistan
  • Muhammad Fawad Ul Qamar Department of Oncology, Shaukat Khanam Memorial Cancer Hospital, & Research Centre Peshawar Pakistan
  • Irfan Haider Department of Oncology, Shaukat Khanam Memorial Cancer Hospital, & Research Centre Peshawar Pakistan

DOI:

https://doi.org/10.51253/pafmj.v74i1.9886

Keywords:

Esophagus, Radiotherapy, Neoplasms, Drug therapy, Gastrostomy, Head and neck neoplasms

Abstract

Objective: To investigate the dependency on feeding gastrostomy tubes in patients with head and neck cancers treated with radiotherapy alone or concurrent chemo-radiotherapy.

Study Design: Retrospective longitudinal study.

Place and Duration of Study: Combined Military Hospital, Rawalpindi and Shaukat Khanum Hospital, Peshawar Pakistan,
from Jan and Jul 2022.

Methodology: A total of 115 patients with head and neck cancers having no baseline dysphagia and having gastrostomy tubes were included. All had received an equivalent of 60 greys in 30 fractions or more of radiotherapy. Their swallowing was evaluated weekly during radiotherapy and then every 4–6 weeks on post-treatment follow-up. The total time duration of patient dependency on feeding gastrostomy tube after treatment completion was noted for each head and neck cancer subsite.
Results: Of a total of 115 patients, 49(43%) of the patients had nasopharyngeal cancers, 22(19%) had laryngeal, 29(24%) oral cavity, 7(6%) hypopharyngeal and 9(8%) had cervical esophageal cancers. Proportion retaining gastrostomy tube for more than six months of treatment was 8.7% (median duration of retention was five months) with hypopharyngeal,
nasopharyngeal, oral cavity, and laryngeal cancer were 14%, 9%, 9% and 5%, respectively.

Conclusion: The proportion of patients with head and neck cancers requiring more than six months of a gastrostomy tube is 5-14%. Baseline assessment of swallowing and nutrition and prophylactic feeding gastrostomy can avoid treatment
interruptions. Longer duration of retention of a gastrostomy tube is associated with poor quality of life in head and neck
cancer patients receiving radiation or concurrent chemo-radiation.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Sung H, FerlayJ, Siegel RL, Laversanne M, Soerjomataram I,

Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN

Estimates of Incidence and Mortality Worldwide for 36 Cancers

in 185 Countries. CA Cancer J Clin 2021; 71(3): 209-249.

https://doi.org/10.3322/caac.21660.

González-Rodríguez M, Villar-Taibo R, Fernández-Pombo A,

Pazos-Couselo M, Sifontes-Dubón MA, Ferreiro-Fariña S, et al.

Early versus conventional nutritional intervention in head and

neck cancer patients before radiotherapy: benefits of a fast-track

circuit. Eur J Clin Nutr 2021; 75(5): 748-753.

https://doi.org/10.1038/s41430-020-00786-1.

Nguyen NP, Smith HJ, Sallah S. Evaluation and management of

swallowing dysfunction following chemoradiation for head and

neck cancer. Curr Opin Otolaryngol Head Neck Surg. 2007; 15(2):

-133. https://doi.org/10.1097/MOO.0b013e32801da0e8.

Pignon JP, le Maître A, Maillard E, Bourhis J; MACH-NC

Collaborative Group. Meta-analysis of chemotherapy in head

and neck cancer (MACH-NC): an update on 93 randomised trials

and 17,346 patients. Radiother Oncol 2009; 92(1): 4-14.

https://doi.org/10.1016/j.radonc.2009.04.014.

Bourhis J, Sire C, Graff P, Grégoire V, Maingon P, Calais G, et al.

Concomitant chemoradiotherapy versus acceleration of

radiotherapy with or without concomitant chemotherapy in

locally advanced head and neck carcinoma (GORTEC 99-02): an

open-label phase 3 randomised trial. Lancet Oncol 2012; 13(2):

-153. https://doi.org/10.1016/S1470-2045(11)70346-1.

Setton J, Lee NY, Riaz N, Huang SH, Waldron J, O'Sullivan B, et

al. A multi-institution pooled analysis of gastrostomy tube

dependence in patients with oropharyngeal cancer treated with

definitive intensity-modulated radiotherapy. Cancer 2015; 121(2):

-301. https://doi.org/10.1002/cncr.29022.

Chera BS, Amdur RJ, Green R, Shen C, Gupta G, Tan X, et al.

Phase II Trial of De-Intensified Chemoradiotherapy for Human

Papillomavirus-Associated Oropharyngeal Squamous Cell

Carcinoma. J Clin Oncol 2019; 37(29): 2661-2669.

https://doi.org/10.1200/JCO.19.01007.

Beaver ME, Matheny KE, Roberts DB, Myers JN. Predictors of

weight loss during radiation therapy. Otolaryngol Head Neck

Surg 2001; 125(6): 645-648.

https://doi.org/10.1067/mhn.2001.120428.

Iro H, Fietkau R, Kolb S. [Nutrition of ENT tumor patients

treated with radiotherapy. Comparison of oral and enteral

nutrition using percutaneous gastrostomy]. HNO 1989; 37(8):

-348.

Anwander T, Bergé S, Appel T, von Lindern JJ, Martini M,

Mommsen J, et al. Percutaneous endoscopic gastrostomy for

long-term feeding of patients with oropharyngeal tumors. Nutr

Cancer 2004; 50(1): 40-45.

https://doi.org/10.1207/s15327914nc5001_6.

Setton J, Lee NY, Riaz N, Huang SH, Waldron J, O'Sullivan B, et

al. A multi-institution pooled analysis of gastrostomy tube

dependence in patients with oropharyngeal cancer treated with

definitive intensity-modulated radiotherapy. Cancer 2015; 121(2):

-301. https://doi.org/10.1002/cncr.29022.

Fietkau R, Iro H, Sailer D, Sauer R. Percutaneous endoscopically

guided gastrostomy in patients with head and neck cancer.

Recent Results Cancer Res 1991; 121: 269-82.

https://doi.org/10.1007/978-3-642-84138-5_31.

Piquet MA, Ozsahin M, Larpin I, Zouhair A, Coti P, Monney M,

et al. Early nutritional intervention in oropharyngeal cancer

patients undergoing radiotherapy. Support Care Cancer 2002;

(6): 502-504. https://doi.org/10.1007/s00520-002-0364-1.

Beer KT, Krause KB, Zuercher T, Stanga Z. Early percutaneous

endoscopic gastrostomy insertion maintains nutritional state in

patients with aerodigestive tract cancer. Nutr Cancer 2005; 52(1):

-34. https://doi.org/10.1207/s15327914nc5201_4.

Nguyen NP, North D, Smith HJ, Dutta S, Alfieri A, Karlsson U,

et al. Safety and effectiveness of prophylactic gastrostomy tubes

for head and neck cancer patients undergoing chemoradiation.

Surg Oncol 2006; 15(4): 199-203.

https://doi.org/10.1016/j.suronc.2006.12.002.

Wiggenraad RG, Flierman L, Goossens A, Brand R, Verschuur

HP, Croll GA, et al. Prophylactic gastrostomy placement and

early tube feeding may limit loss of weight during chemoradiotherapy for advanced head and neck cancer, a preliminary

study. Clin Otolaryngol 2007; 32(5): 384-390.

https://doi.org/10.1111/j.1749-4486.2007.01533.x.

Bourhis J, Sire C, Graff P, Grégoire V, Maingon P, Calais G, et al.

Concomitant chemoradiotherapy versus acceleration of

radiotherapy with or without concomitant chemotherapy in

locally advanced head and neck carcinoma (GORTEC 99-02): an

Downloads

Published

28-02-2024

How to Cite

Sheikh, R., Nadeem, M. S., Nadia Khaleeq, Muhammad Fawad Ul Qamar, & Irfan Haider. (2024). Assessing the Dependence of Feeding Gastrostomy Tube in Patients of Head and Neck Carcinomas. Pakistan Armed Forces Medical Journal, 74(1), 89–93. https://doi.org/10.51253/pafmj.v74i1.9886

Issue

Section

Original Articles

Most read articles by the same author(s)